Oncquest Laboratories Profile
Key Indicators
- Authorised Capital ₹ 38.00 Cr
as on 08-11-2024
- Paid Up Capital ₹ 38.00 Cr
as on 08-11-2024
- Company Age 17 Year, 21 Days
- Last Filing with ROC 31 Mar 2024
- Revenue 0.27%
(FY 2023)
- Profit -41.56%
(FY 2023)
- Ebitda -64.08%
(FY 2023)
- Net Worth -206.39%
(FY 2023)
- Total Assets 5.13%
(FY 2023)
About Oncquest Laboratories
The Corporate was formerly known as Oncquest Laboratories Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 38.00 Cr and a paid-up capital of Rs 38.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Oncquest Laboratories Limited India are Vandana Wadhwa as CFO and Swati Rawat as Company Secretary. Aditya Burman, Shailendra Tandon, Gaurav Chamaria, and One other member serve as directors at the Company.
- CIN/LLPIN
U24233DL2007PLC170898
- Company No.
170898
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
29 Nov 2007
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Oncquest Laboratories?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swati Rawat  | Company Secretary | 17-Oct-2024 | Current |
| Vandana Wadhwa | CFO | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajiv Kapoor | Director | 12-Feb-2024 | Current |
| Gaurav Chamaria | Director | 26-Oct-2023 | Current |
| Aditya Burman | Director | 29-Nov-2007 | Current |
| Shailendra Tandon | Director | 31-Mar-2015 | Current |
Financial Performance and Corporate Structure Insights of Oncquest Laboratories.
Oncquest Laboratories Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.27% increase. The company also saw a substantial fall in profitability, with a 41.56% decrease in profit. The company's net worth observed a substantial decline by a decrease of 206.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oncquest Laboratories?
In 2023, Oncquest Laboratories had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Oncquest Laboratories?
Oncquest Laboratories has a workforce of 739 employees as of Nov 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oncquest Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oncquest Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
